You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Descovy

Showing 1 - 25 of 38
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Prevention Trial in Brazil, United States (Immediate Intervention Arm Truvada in the US, Deferred Intervention Arm Truvada

Enrolling by invitation
  • HIV Prevention
  • Immediate Intervention Arm Truvada in the US
  • +5 more
  • San Francisco, California
  • +4 more
Aug 30, 2022

Express Testing and Same-day Initiation of PrEP Study

Recruiting
  • HIV Prevention
  • Descovy
  • Toronto, Ontario, Canada
    HQ Toronto
Jan 26, 2023

PrEPared-RN, CAN Nurse-Led Management of High-risk Pre-Exposure

Recruiting
  • Hiv Prevention
  • Pre-Exposure Prophylaxis (PrEP)
  • Fort Lauderdale, Florida
  • +4 more
Sep 7, 2023

HIV Trial in Thika (co-formulated 25mg TAF/ 200mg FTC)

Recruiting
  • HIV Infections
  • co-formulated 25mg TAF/ 200mg FTC
  • Thika, Kenya
    Kenya Medical Research Institute - Partners in Health Research a
Jan 24, 2023

HIV, Substance Use, Adherence, Medication Trial in Boston (Descovy or Truvada, ID-Cap System, Beiwe)

Recruiting
  • HIV Infections
  • +3 more
  • Descovy or Truvada
  • +2 more
  • Boston, Massachusetts
    Fenway Health
Dec 20, 2022

Hiv, Hormone Therapy Trial in San Diego (Emtricitabine / Tenofovir Disoproxil Oral Tablet 200/300 mg, Emtricitabine Tenofovir

Completed
  • Hiv
  • Hormone Therapy
  • Emtricitabine / Tenofovir Disoproxil Oral Tablet 200/300 mg
  • Emtricitabine Tenofovir Alafenamide 200/25 mg
  • San Diego, California
    UC San Diego AntiViral Research Center (AVRC)
Sep 21, 2022

Hiv, Substance Use Disorders Trial in Miami (Descovy 200Mg 25Mg Tablet, PrEP)

Recruiting
  • Hiv
  • Substance Use Disorders
  • Descovy 200Mg 25Mg Tablet
  • PrEP
  • Miami, Florida
    University of Miami
Mar 4, 2022

Acceptability of Health Care, Adherence, Medication Trial in Durban, Pietermaritzburg, Harare (emtricitabine/tenofovir

Recruiting
  • Acceptability of Health Care
  • Adherence, Medication
  • emtricitabine/tenofovir alafenamide
  • Emtricitabine / Tenofovir Disoproxil Oral Tablet
  • Durban, KZN, South Africa
  • +2 more
Jul 12, 2022

HIV-1-infection Trial in L'Hospitalet De Llobregat (Doravirine, Descovy)

Completed
Has Results
  • HIV-1-infection
  • L'Hospitalet De Llobregat, Barcelona, Spain
    Hospital Universitari de Bellvitge
Apr 27, 2022

HIV I Infection, Cardiovascular Risk Factor, Lipid Metabolism Disorders Trial (Doravirine 100 Mg)

Recruiting
  • HIV I Infection
  • +2 more
  • Doravirine 100 Mg
  • Los Angeles, California
  • +1 more
Nov 1, 2022

HIV/AIDS Trial in Paris, Chiang Mai (TDF/FTC 300mg/200mg fixed-dose combination tablets, TAF/FTC 25mg/200mg fixed-dose

Not yet recruiting
  • HIV/AIDS
  • TDF/FTC 300mg/200mg fixed-dose combination tablets
  • TAF/FTC 25mg/200mg fixed-dose combination tablets
  • Paris, France
  • +1 more
Apr 3, 2023

Body Weight Changes, Human Immunodeficiency Virus, ART Trial in Dallas (DOR/3TC/TDF, DOR + FTC/TAF, BIC/FTC/TAF)

Not yet recruiting
  • Body Weight Changes
  • +7 more
  • Dallas, Texas
    Prism Health North Texas
Jul 12, 2022

Osteoporosis, HIV, Menopause Trial in Canada, Italy (tenofovir-alafenamide-emtricitabine, tenofovir-emtricitabine)

Completed
Has Results
  • Osteoporosis
  • +2 more
  • Vancouver, British Columbia, Canada
  • +6 more
Dec 22, 2022

Human Immunodeficiency Virus Trial in Baltimore (dolutegravir and descovy)

Completed
  • Human Immunodeficiency Virus
  • dolutegravir and descovy
  • Baltimore, Maryland
    Johns Hopkins University
Sep 13, 2021

Medication Adherence, HIV Trial in Pittsburgh (dolutegravir oral tablet 50mg, emtricitabine/tenofovir alafenamide oral tablet

Completed
  • Medication Adherence
  • HIV
  • dolutegravir oral tablet 50mg
  • +3 more
  • Pittsburgh, Pennsylvania
    HIV/AIDS Clinical Research Unit / University of Pittsburgh
Mar 2, 2022

HIV Trial in Canada (PrEP, mHealth Model of Care, Standard of Care)

Not yet recruiting
  • HIV Infections
  • Calgary, Alberta, Canada
  • +4 more
Dec 6, 2021

Hepatitis C, HIV Coinfection Trial in Aurora (TDF with a boosted protease inhibitor, TAF with a boosted protease inhibitor, TAF

Completed
Has Results
  • Hepatitis C
  • HIV Coinfection
  • TDF with a boosted protease inhibitor
  • +2 more
  • Aurora, Colorado
    University of Colorado Hospital
Jan 21, 2021

Healthy Volunteers Trial in Aurora (emtricitabine 200 mg/tenofovir alafenamide 25mg)

Completed
Has Results
  • Healthy Volunteers
  • emtricitabine 200 mg/tenofovir alafenamide 25mg
  • Aurora, Colorado
    University of Colorado- Anschutz Campus
Jan 22, 2021

Pre-Exposure Prophylaxis of HIV Infection Trial in South Africa, Uganda (Oral Lenacapavir (LEN), Subcutaneous (SC) Lenacapavir

Recruiting
  • Pre-Exposure Prophylaxis of HIV Infection
  • Oral Lenacapavir (LEN)
  • +7 more
  • Brits, South Africa
  • +18 more
Aug 19, 2022

HIV Preexposure Prophylaxis Trial in Worldwide (ISL, FTC/TDF, FTC/TAF)

Active, not recruiting
  • HIV Preexposure Prophylaxis
  • Birmingham, Alabama
  • +24 more
Aug 15, 2022

HIV-1-infection Trial in Milan (SYMTUZA, DESCOVY+DOLUTEGRAVIR, SYMTUZA+DOLUTEGRAVIR)

Unknown status
  • HIV-1-infection
  • SYMTUZA
  • +2 more
  • Milan, MI, Italy
    Ospedale San Raffaele
Jan 8, 2020

Renal Insufficiency,Chronic, Hiv, Therapeutic Agent Toxicity Trial in Arnhem, Amsterdam, Rotterdam (tenofovir alafenamide,

Unknown status
  • Renal Insufficiency,Chronic
  • +2 more
  • Arnhem, Gelderland, Netherlands
  • +4 more
Jan 27, 2020

Pre-Exposure Prophylaxis of HIV-1 Infection Trial in Worldwide (F/TAF, F/TDF, F/TAF Placebo)

Active, not recruiting
Has Results
  • Pre-Exposure Prophylaxis of HIV-1 Infection
  • Beverly Hills, California
  • +92 more
Jun 28, 2022

HIV Trial (Estoy PrEParado/ I am PrEPared intervention)

Not yet recruiting
  • HIV
  • Estoy PrEParado/ I am PrEPared intervention
  • (no location specified)
Jun 21, 2022

HIV Trial in San Diego (Digital Health Feedback System)

Active, not recruiting
  • HIV
  • Digital Health Feedback System
  • San Diego, California
  • +1 more
Dec 21, 2022